These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 27748520

  • 1. Maternal HLA genotyping is not useful for predicting severity of fetal and neonatal alloimmune thrombocytopenia.
    Sainio S, Javela K, Tuimala J, Haimila K.
    Br J Haematol; 2017 Jan; 176(1):111-117. PubMed ID: 27748520
    [Abstract] [Full Text] [Related]

  • 2. HLA-DRB3*01:01 is a predictor of immunization against human platelet antigen-1a but not of the severity of fetal and neonatal alloimmune thrombocytopenia.
    Wienzek-Lischka S, König IR, Papenkort EM, Hackstein H, Santoso S, Sachs UJ, Bein G.
    Transfusion; 2017 Mar; 57(3):533-540. PubMed ID: 28019029
    [Abstract] [Full Text] [Related]

  • 3. Compound heterozygosity of HLA-DRB3*01:01 and HLA-DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia.
    Loewenthal R, Rosenberg N, Kalt R, Dardik R, Landau M, Yahalom V, Avishai O, Frenkel O, Gazit E, Steinberg DM, Lipitz S, Salomon O.
    Transfusion; 2013 Feb; 53(2):344-52. PubMed ID: 22671039
    [Abstract] [Full Text] [Related]

  • 4. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
    Kjeldsen-Kragh J, Bengtsson J.
    Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
    [Abstract] [Full Text] [Related]

  • 5. Foetal and neonatal alloimmune thrombocytopenia - The role of the HLA-DRB3*01:01 allele for HPA-1a-immunisation and foetal/neonatal outcome.
    Kjeldsen-Kragh J, Ahlen MT.
    Transfus Apher Sci; 2020 Feb; 59(1):102707. PubMed ID: 31919011
    [Abstract] [Full Text] [Related]

  • 6. The prevalence of HPA-1a alloimmunization and the potential risk of FNAIT depend on both the DRB3*01:01 allele and associated DR-DQ haplotypes.
    Ahlen MT, Heide G, Husebekk A, Skogen B, Kjeldsen-Kragh J, Stuge TB.
    Scand J Immunol; 2020 Jul; 92(1):e12890. PubMed ID: 32299122
    [Abstract] [Full Text] [Related]

  • 7. Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage.
    Delbos F, Bertrand G, Croisille L, Ansart-Pirenne H, Bierling P, Kaplan C.
    Transfusion; 2016 Jan; 56(1):59-66; quiz 58. PubMed ID: 26469867
    [Abstract] [Full Text] [Related]

  • 8. HLA-DRB3*01:01 exhibits a dose-dependent impact on HPA-1a antibody levels in HPA-1a-immunized women.
    Kjeldsen-Kragh J, Titze TL, Lie BA, Vaage JT, Kjær M.
    Blood Adv; 2019 Apr 09; 3(7):945-951. PubMed ID: 30923048
    [Abstract] [Full Text] [Related]

  • 9. Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia.
    de Vos TW, Porcelijn L, Hofstede-van Egmond S, Pajkrt E, Oepkes D, Lopriore E, van der Schoot CE, Winkelhorst D, de Haas M.
    Br J Haematol; 2021 Nov 09; 195(4):595-603. PubMed ID: 34402048
    [Abstract] [Full Text] [Related]

  • 10. Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review.
    Kamphuis MM, Paridaans N, Porcelijn L, De Haas M, Van Der Schoot CE, Brand A, Bonsel GJ, Oepkes D.
    BJOG; 2010 Oct 09; 117(11):1335-43. PubMed ID: 20618318
    [Abstract] [Full Text] [Related]

  • 11. Maternal antibodies against paternal class I human leukocyte antigens are not associated with foetal and neonatal alloimmune thrombocytopenia.
    Sachs UJ, Wienzek-Lischka S, Duong Y, Qiu D, Hinrichs W, Cooper N, Santoso S, Bayat B, Bein G.
    Br J Haematol; 2020 May 09; 189(4):751-759. PubMed ID: 31997312
    [Abstract] [Full Text] [Related]

  • 12. Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review.
    Kjaer M, Bertrand G, Bakchoul T, Massey E, Baker JM, Lieberman L, Tanael S, Greinacher A, Murphy MF, Arnold DM, Baidya S, Bussel J, Hume H, Kaplan C, Oepkes D, Ryan G, Savoia H, Shehata N, Kjeldsen-Kragh J, International Collaboration for Transfusion Medicine Guidelines.
    Vox Sang; 2019 Jan 09; 114(1):79-94. PubMed ID: 30565711
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Taking a wider view on fetal/neonatal alloimmune thrombocytopenia.
    Bonstein L, Haddad N.
    Thromb Res; 2017 Mar 09; 151 Suppl 1():S100-S102. PubMed ID: 28262226
    [Abstract] [Full Text] [Related]

  • 15. Human platelet antigen (HPA)-1a peptides do not reliably suppress anti-HPA-1a responses using a humanized severe combined immunodeficiency (SCID) mouse model.
    Jackson DJ, Eastlake JL, Kumpel BM.
    Clin Exp Immunol; 2014 Apr 09; 176(1):23-36. PubMed ID: 24261689
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Usefulness of maternal anti-HPA-1a antibody quantitation in predicting severity of foetomaternal alloimmune thrombocytopenia.
    Sainio S, Javela K, Tuimala J, Koskinen S.
    Transfus Med; 2013 Apr 09; 23(2):114-20. PubMed ID: 23448161
    [Abstract] [Full Text] [Related]

  • 18. Prevalence and clinical significance of low-avidity HPA-1a antibodies in women exposed to HPA-1a during pregnancy.
    Peterson JA, Kanack A, Nayak D, Bougie DW, McFarland JG, Curtis BR, Aster RH.
    Transfusion; 2013 Jun 09; 53(6):1309-18. PubMed ID: 23003125
    [Abstract] [Full Text] [Related]

  • 19. [PREVFNAIT prevention of foetal/neonatal alloimmune thrombocytopenia (FNAIT) in Polish foetuses and newborns--the PREVFNAIT program].
    Uhrynowska ME, Dębska M, Guz K, Orzińska A, Wróbel A, Maślanka K, Dębski R, Brojer E.
    Ginekol Pol; 2015 Jan 09; 86(1):62-6. PubMed ID: 25775877
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.